EMERYVILLE, Calif.--(BUSINESS WIRE)--Tethys Bioscience, Inc., a privately held cardiometabolic diagnostics company, and the United States Air Force have established a collaboration to study the impact of the PreDx® Diabetes Risk Score on behavioral change, the key component in reducing the incidence of type 2 diabetes, among the Air Force’s retirees and dependents. Type 2 diabetes is a serious, costly and growing healthcare risk within the military’s large retiree population. Diabetes can be prevented, however, with improvements in lifestyle, including diet, nutrition and exercise. A common obstacle to lifestyle changes is lack of compliance among at-risk individuals.
